Apr 1, 2014 9:00 AM
The pilot phase of work by the China Kadoorie Biobank to assess the quality of diagnosis of COPD cases obtained from health insurance database has been completed for ~1,100 randomly selected cases from all the ten regional centres.
Mar 30, 2014 9:00 AM
In collaboration with genotyping microarray manufacturer Affymetrix and our genomics partner in China, BGI-Shenzhen, the China Kadoorie Biobank team has completed the design of a low cost biobanking genotyping array optimised for Chinese populations.
Mar 17, 2014 12:00 PM
China has experienced major social and economic changes over the last several decades, and data from the China Kadoorie Biobank, published online in the International Journal of Epidemiology, showed striking changes in women’s reproductive factors over this period.
Mar 11, 2014 12:00 PM
DNA extraction has been completed for 150,000 CKB participants.
Mar 10, 2014 2:00 PM
Despite the high burden of COPD, there is still little data available from China about the prevalence of spirometrically diagnosed COPD among never smokers.
Mar 3, 2014 10:00 AM
The second phase of the China Kadoorie Biobank resurvey was launched successfully in March 2014.
Feb 15, 2014 11:00 AM
So far over 15,000 incident and recurrent cases of cancer have been reported in the China Kadoorie Biobank.
Dec 28, 2013 12:00 PM
Little is known about the long-term use of various proven secondary preventive treatments among patients with cardiovascular diseases (CVD) in the general Chinese population. Findings from the China Kadoorie Biobank cross-sectional data, published online in the Journal of International Cardiology on December 28, 2014, showed that only 1 in 3 individuals with a history of physician-diagnosed CVD received any of the established secondary preventive treatments (eg, aspirin, statins, beta-blockers, diuretics, ACE-I, or calcium-channel blockers). These results should help inform disease prevention and effective delivery of health care service in China.
Dec 12, 2013 10:00 AM
There is little direct evidence in China about the role of diabetes as a risk factor for cardiovascular disease, and less still about the association of blood glucose levels below the threshold for diabetes with cardiovascular disease.
Nov 25, 2013 10:00 AM
The National Natural Science Foundation of China (NSFC) has awarded a 5-year program grant to the China Kadoorie Biobank team in China to undertake research into the genetic and non-genetic causes of ischaemic heart disease (IHD) and ischaemic stroke.